PCV17 COST-EFFECTIVENESS ANALYSIS OF DALTEPARIN IN PROLONGED PROPHYLAXIS AGAINST DEEP VEIN THROMBOSIS AFTER HIP ARTHROPLASTY
Nov 1, 2003, 00:00 AM
10.1016/S1098-3015(10)61661-0
https://www.valueinhealthjournal.com/article/S1098-3015(10)61661-0/fulltext
Section Title :
Section Order :
107
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)61661-0&doi=10.1016/S1098-3015(10)61661-0